0.7000USD0.00%Mkt Cap: 1.24M USDP/E: —Last update: 2026-06-01
Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology i…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.24M USD
Enterprise Value15.68M USD
Revenue (TTM)398.00K USD
Gross Profit-608.00K USD
Net Income (TTM)-28.92M USD
Revenue/Share0.2560 USD
Last Price0.7000 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees27
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.71
PEG—
EV/EBITDA-0.54
EV/Revenue39.40
P/S3.12
P/B-0.12
EPS (TTM)-18.62
EPS (Forward)-0.99
52W Range
0.31001% of range37.50
52W High37.50 USD
52W Low0.3100 USD
Profitability
Gross Margin-152.76%
Oper. Margin-98728.57%
EBITDA Margin0.00%
Profit Margin-7266.08%
ROE269.84%
ROA-80.09%
Growth
Revenue Growth-96.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.86M USD
CapEx (TTM)116.00K USD
FCF Margin-4404.43%
FCF Yield-1410.93%
Net Debt14.37M USD
Net Debt/EBITDA-0.49
Balance Sheet
Debt/Equity-2.82
Current Ratio1.71
Quick Ratio1.67
Book Value/Sh-6.0380 USD
Cash/Share8.954 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.77M
Float336.13K
Insiders0.62%
Institutions13.26%
Short Interest
Short Ratio0.3d
Short % Float1.10%
Short % Out.0.93%
Shares Short16.53K
Short (prev mo.)59.09K
Technical
SMA 500.6530 (+7.2%)
SMA 2003.223 (-78.3%)
Beta0.69
S&P 52W Chg27.94%
Avg Vol (30d)7.62K
Avg Vol (10d)6.53K
Technical Indicators
RSI (14)47.0
MACD-0.0030
MACD Signal-0.0037
MACD Hist.+0.0007
BB Upper0.7787 USD
BB Middle0.7273 USD
BB Lower0.6759 USD
BB Width14.13%
ATR (14)0.0786 USD
Vol Ratio (20d)0.13x